Description
U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market Industry Overview
The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market is segmented into U.S. orthopedic imaging modalities market and U.S. orthopedic surgical navigation systems market. The report highlights that the U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is expected to reach $3,989.9 million by the end of 2031. The market is expected to grow at a CAGR of 4.44% during the forecast period 2022-2031. The market is driven by factors such as technological advancements in the imaging field, the increasing incidences of orthopedic diseases and bone injuries, and the growing demand for point of care (POC) ultrasound systems in orthopedic applications. In addition to this, the report also highlights that the U.S. orthopedic surgical navigation systems market was valued at $262.9 million in 2022 and is expected to reach $460.9 million by the end of 2031. The market is expected to grow at a CAGR of 6.43% during the forecast period 2022-2031. The market is driven by factors such as the increasing number of joint replacement surgery and the increasing preference for minimally invasive surgery.
Market Lifecycle Stage
The U.S. orthopedic imaging modalities market is in the developed phase. The rising incidence of orthopedic indications and the upsurge in technological advancements are some of the major opportunities in the U.S. orthopedic imaging modalities market. Furthermore, some of the current key trends in the market are the inclination toward magnetic resonance imaging (MRI) systems and the integration of artificial intelligence (AI) in imaging modalities.
On the other hand, the U.S. orthopedic surgical navigation systems market is in the developing phase. The increasing preference for minimally invasive surgeries (MIS) and rising numbers of joint replacement surgeries are some of the major opportunities in the U.S. orthopedic surgical navigation systems market.
Impact of COVID-19
The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market. The COVID-19 pandemic led to a decline in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems devices market, as screening, elective, and surgical procedures were stopped during the lockdown.
Overall, the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic. The significantly high number of screening, elective, and surgical procedures resumed after the restrictions were lifted, which offset the negative impact and led to the growth of the market in 2021.
In addition to this, the COVID-19 pandemic also helped in the adoption of disposable access devices and hand instruments. Single-use devices eliminate the risk of cross-contamination, which turned out to be a favorable condition for their adoption during the COVID-19 pandemic.
Market Segmentation:
U.S. Orthopedic Imaging Modalities Market
Segmentation 1: by Application
• Hip
• Knee
• Spine
• Other Extremities
The U.S. orthopedic imaging modalities devices market (by application) is expected to be dominated by the spine segment.
Segmentation 2: by Modality
• X-Ray
• Computed Tomography (CT) Scanners
• Magnetic Resonance Imaging (MRI) Systems
• Ultrasound Systems
The U.S. orthopedic imaging modalities devices market (by modality) is expected to be dominated by the X-Ray segment.
Segmentation 3: by End User
• Hospitals
• Ambulatory Surgery Centers
• Others
The U.S. orthopedic imaging modalities devices market (by end user) is dominated by the hospitals segment.
U.S. Orthopedic Surgical Navigation Systems Market
Segmentation 1: by Application
• Joints
• Spine
The U.S. orthopedic surgical navigation systems market (by application) is expected to be dominated by the spine segment.
Recent Developments in the U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market
Demand – Drivers and Limitations
U.S. Orthopedic Imaging Modalities Market
The following are the drivers for the U.S. orthopedic imaging modalities market:
• Technological Advancements in Imaging
• Increasing Incidences of Orthopedic Diseases and Bone Injuries
• Growing Demand for POC Ultrasound Systems in Orthopedic
The market is expected to face some limitations as well due to the following challenges:
• Health Risks and Healthcare Costs from Potentially Inappropriate High-Cost Imaging
• Recall of Imaging Systems
U.S. Orthopedic Surgical Navigation Systems Market
The following are the drivers for the U.S. orthopedic surgical navigation systems market:
• Increasing Number of Joint Replacement Surgeries
• Increasing Preference for Minimally Invasive Procedures
The market is expected to face some limitations as well due to the following challenges:
• High Cost of Robotic Navigation System
How can this report add value to an organization?
U.S. Orthopedic Imaging Modalities Market
Application: The application segment helps readers understand the various applications of U.S. orthopedic imaging modalities in the market.
Modality: The modality segment helps the readers understand the different types of modalities available and their significance in the U.S. orthopedic imaging modalities market. Moreover, the study provides the readers with a detailed understanding of the four main segments, namely, X-Ray, computed tomography (CT) scanners, magnetic resonance imaging (MRI) systems, and ultrasound systems.
U.S. Orthopedic Surgical Navigation Systems Market
Application: The application segment helps readers understand the various applications of U.S. orthopedic surgical navigation systems in the market.
U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market
Growth/Marketing Strategy: The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, and regulatory and legal approvals. The most favored strategy for the companies has been regulatory and legal activities and new offerings to strengthen their position in the market. For instance, in February 2022, FUJIFILM Holdings Corporation launched the Sonosite LX ultrasound system, and in August 2021, DePuy Synthes, a subsidiary of Johnson & Johnson, received FDA clearance for VELYS robotic-assisted solution.
Competitive Strategy: The key players in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market analyzed and profiled in the study involve established and emerging players that offer different products for visualization of the joints and spine for diagnostic as well as therapeutic purposes. Moreover, a detailed competitive benchmarking of the players operating in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Key Companies Profiled
• Canon Inc.
• FUJIFILM Holdings Corporation
• General Electric Company
• Johnson & Johnson
• Konica Minolta, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• OrthAlign, Inc.
• Shimadzu Corporation
• Siemens Healthineers AG
• Smith & Nephew plc
• SonoScape Medical Corp.
• Stryker Corporation
• United Imaging Healthcare Co., Ltd.
• Zimmer Biomet Holdings, Inc.
Table of Contents
1 Market
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Market Scenario
1.1.5.1 U.S. Orthopedic Imaging Modalities Market
1.1.5.1.1 Realistic Growth Scenario
1.1.5.1.2 Optimistic Growth Scenario
1.1.5.1.3 Pessimistic Growth Scenario
1.1.5.2 U.S. Orthopedic Surgical Navigation Systems Market
1.1.5.2.1 Realistic Growth Scenario
1.1.5.2.2 Optimistic Growth Scenario
1.1.5.2.3 Pessimistic Growth Scenario
1.2 Industry Outlook
1.2.1 Patent Analysis
1.2.1.1 U.S. Orthopedic Imaging Modalities Market
1.2.1.1.1 Patent Analysis (by Year)
1.2.1.1.2 Awaited Technological Developments
1.2.1.2 U.S. Orthopedic Surgical Navigation Systems Market
1.2.1.2.1 Patent Analysis (by Year)
1.2.1.2.2 Awaited Technological Developments
1.2.2 Regulatory Landscape
1.2.3 Product Benchmarking
1.3 Impact of COVID-19 on the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
1.3.1 Impact on Facilities
1.3.2 Impact on Modalities Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During-COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.4 Business Dynamics
1.4.1 U.S. Orthopedic Imaging Modalities Market
1.4.1.1 Impact Analysis
1.4.1.2 Business Drivers
1.4.1.2.1 Technological Advancement in Imaging
1.4.1.2.2 Increasing Incidences of Orthopedic Diseases and Bone Injuries
1.4.1.2.3 Growing Demand for Point-of-Care Ultrasound Systems (POCUS) in Orthopedics
1.4.1.3 Business Restraints
1.4.1.3.1 Health Risks and Healthcare Costs Arising from Potentially Inappropriate High-Cost Imaging
1.4.1.3.2 Recall of Imaging Systems
1.4.1.4 Business Opportunities
1.4.1.4.1 Leveraging Partnerships to Expand Business Opportunities
1.4.1.4.2 Increase in Usage of Dual Modality Imaging or Hybrid Imaging
1.4.1.5 Business Trends
1.4.2 U.S. Orthopedic Surgical Navigation Systems Market
1.4.2.1 Impact Analysis
1.4.2.2 Business Drivers
1.4.2.2.1 Increasing Number of Joint Replacement Surgeries
1.4.2.2.2 Increasing Preference for Minimally Invasive Procedures
1.4.2.3 Business Restraints
1.4.2.3.1 High Cost of Robotic Orthopedic Surgical Navigation System
1.4.2.4 Business Opportunities
1.4.2.4.1 Leveraging Synergies to Diversify Business Portfolio
2 U.S. Orthopedic Imaging Modalities Market (by Application)
2.1 Overview
2.2 Growth-Share Matrix
2.3 Hip
2.4 Knee
2.5 Spine
2.6 Other Extremities
3 U.S. Orthopedic Imaging Modalities Market (by Modality)
3.1 Overview
3.2 Growth-Share Matrix
3.3 X-Ray
3.3.1 Market Dynamics
3.3.2 Procedure Volume
3.3.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.3.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.3.3 Market Size and Forecast
3.3.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.4 Computed Tomography (CT) Scanners
3.4.1 Market Dynamics
3.4.2 Procedure Volume
3.4.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.4.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.4.3 Market Size and Forecast
3.4.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.5 Magnetic Resonance Imaging (MRI) Systems
3.5.1 Market Dynamics
3.5.2 Procedure Volume
3.5.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.5.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.5.3 Market Size and Forecast
3.5.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.6 Ultrasound Systems
3.6.1 Market Dynamics
3.6.2 Procedure Volume
3.6.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.6.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.6.3 Market Size and Forecast
3.6.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
4 U.S. Orthopedic Imaging Modalities Market (by End User)
4.1 Overview
4.2 Growth-Share Matrix
4.3 Hospitals
4.4 Ambulatory Surgical Centers
4.5 Others
5 U.S. Orthopedic Surgical Navigation Systems Market (by Application)
5.1 Overview
5.2 Growth-Share Matrix
5.3 Joints
5.4 Spine
6 Market – Competitive Benchmarking & Company Profiles
6.1 Competitive Benchmarking
6.1.1 Competitive Landscape
6.1.1.1 Key Strategies and Developments
6.1.1.2 Regulatory and Legal Activities
6.1.1.3 New Offerings
6.1.1.4 Mergers and Acquisitions
6.1.1.5 Partnerships, Collaborations, and Business Expansion Activities
6.1.2 Key Development Analysis
6.2 Company Profiles
6.2.1 Canon Inc.
6.2.1.1 Company Overview
6.2.1.2 Role of Canon Inc. in the U.S. Orthopedics Imaging Modalities and Surgical Navigation Systems Market
6.2.1.3 Product Portfolio
6.2.1.4 Financials
6.2.1.5 Recent Developments
6.2.1.6 Analyst Perception
6.2.2 FUJIFILM Holdings Corporation
6.2.2.1 Company Overview
6.2.2.2 Role of FUJIFILM Holdings Corporation in the U.S. Orthopedics Imaging Modalities and Surgical Navigation Systems Market
6.2.2.3 Product Portfolio
6.2.2.4 Financials
6.2.2.5 Recent Developments
6.2.2.6 Analyst Perception
6.2.3 General Electric Company
6.2.3.1 Company Overview
6.2.3.2 Role of General Electric Company in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.3.3 Product Portfolio
6.2.3.4 Financials
6.2.3.5 Recent Developments
6.2.3.6 Analyst Perception
6.2.4 Johnson & Johnson
6.2.4.1 Company Overview
6.2.4.2 Role of Johnson & Johnson in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.4.3 Product Portfolio
6.2.4.4 Financials
6.2.4.5 Recent Developments
6.2.4.6 Analyst Perception
6.2.5 Konica Minolta, Inc.
6.2.5.1 Company Overview
6.2.5.2 Role of Konica Minolta Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.5.3 Product Portfolio
6.2.5.4 Financials
6.2.5.5 Analyst Perspectives
6.2.6 Koninklijke Philips N.V.
6.2.6.1 Company Overview
6.2.6.2 Role of Koninklijke Philips N.V. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.6.3 Product Portfolio
6.2.6.4 Financials
6.2.6.5 Recent Developments
6.2.6.6 Analyst Perception
6.2.7 Medtronic plc
6.2.7.1 Company Overview
6.2.7.2 Role of Medtronic plc in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.7.3 Product Portfolio
6.2.7.4 Financials
6.2.7.5 Recent Developments
6.2.7.6 Analyst Perception
6.2.8 OrthAlign, Inc.
6.2.8.1 Company Overview
6.2.8.2 Role of OrthAlign, Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.8.3 Product Portfolio
6.2.8.4 Recent Developments
6.2.8.5 Analyst Perception
6.2.9 Shimadzu Corporation
6.2.9.1 Company Overview
6.2.9.2 Role of Shimadzu Corporation in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.9.3 Product Portfolio
6.2.9.4 Financials
6.2.9.5 Recent Developments
6.2.9.6 Analyst Perception
6.2.10 Siemens Healthineers AG
6.2.10.1 Company Overview
6.2.10.2 Role of Siemens Healthineers AG in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.10.3 Product Portfolio
6.2.10.4 Financials
6.2.10.5 Recent Developments
6.2.10.6 Analyst Perspectives
6.2.11 Smith & Nephew plc
6.2.11.1 Company Overview
6.2.11.2 Role of Smith & Nephew plc in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.11.3 Product Portfolio
6.2.11.4 Financials
6.2.11.5 Analyst Perception
6.2.12 SonoScape Medical Corp.
6.2.12.1 Company Overview
6.2.12.2 Role of SonoScape Medical Corp. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.12.3 Product Portfolio
6.2.12.4 Analyst Perception
6.2.13 Stryker Corporation
6.2.13.1 Company Overview
6.2.13.2 Role of Stryker Corporation in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.13.3 Product Portfolio
6.2.13.4 Financials
6.2.13.5 Analyst Perception
6.2.14 United Imaging Healthcare Co., Ltd.
6.2.14.1 Company Overview
6.2.14.2 Role of United Imaging Healthcare Co., Ltd. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.14.3 Product Portfolio
6.2.14.4 Recent Developments
6.2.14.5 Analyst Perception
6.2.15 Zimmer Biomet Holdings, Inc.
6.2.15.1 Company Overview
6.2.15.2 Role of Zimmer Biomet Holdings, Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.15.3 Product Portfolio
6.2.15.4 Financials
6.2.15.5 Recent Developments
6.2.15.6 Analyst Perception
List of Figures
Figure 1: U.S. Orthopedic Imaging Modalities Market, $Million, 2020-2031
Figure 2: U.S. Orthopedic Imaging Modalities Market Dynamics, Impact Analysis
Figure 3: U.S. Orthopedic Surgical Navigation Systems Market, $Million, 2020-2031
Figure 4: U.S. Orthopedic Surgical Navigation Systems Market Dynamics, Impact Analysis
Figure 5: Segmentation of U.S. Orthopedic Imaging Modalities Market, $Million, 2020-2031
Figure 6: Segmentation of U.S. Orthopedic Surgical Navigation Systems Market, $Million, 2020-2031
Figure 7: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Research Methodology
Figure 8: Primary Research
Figure 9: Secondary Research
Figure 10: Data Triangulation
Figure 11: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Research Process
Figure 12: Assumptions and Limitations
Figure 13: U.S. Orthopedic Imaging Modalities Market, Potential Forecast Scenarios
Figure 14: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
Figure 15: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
Figure 16: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Pessimistic Scenario), $Million, 2020-2031
Figure 17: U.S. Orthopedic Surgical Navigation Systems Market, Potential Forecast Scenarios
Figure 18: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
Figure 19: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
Figure 20: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Pessimistic Scenario), $Million, 2020-2031
Figure 21: U.S. Orthopedic Imaging Modalities Market, Patent Analysis (by Year), January 2018-September 2022
Figure 22: U.S. Orthopedic Surgical Navigation Systems Market, Patent Analysis (by Year), January 2018-September 2022
Figure 23: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Orthopedic Imaging Modalities (by Modality), Product Benchmarking
Figure 24: U.S. Orthopedic Imaging Modalities Market, Impact Analysis
Figure 25: Recent Advances in Imaging and Radiology in Orthopedics
Figure 26: U.S. Orthopedic Imaging Modalities Market, Business Trends
Figure 27: U.S. Orthopedic Surgical Navigation Systems Market, Impact Analysis
Figure 28: Total Knee Arthroplasty, Procedure Volume, Unit, 2020-2040
Figure 29: Total Hip Arthroplasty, Procedure Volume, Unit, 2020-2040
Figure 30: Post-Operative Complications, Minimally Invasive Surgeries (MIS) vs. Open Procedure, 2019
Figure 31: U.S. Orthopedic Imaging Modalities Market (by Application)
Figure 32: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by Application), 2021-2031
Figure 33: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by Application), 2021-2031
Figure 34: U.S. Orthopedic Imaging Modalities Market (Hip), $Million, 2020-2031
Figure 35: U.S. Orthopedic Imaging Modalities Market (Knee), $Million, 2020-2031
Figure 36: U.S. Orthopedic Imaging Modalities Market (Spine), $Million, 2020-2031
Figure 37: U.S. Orthopedic Imaging Modalities Market (Other Extremities), $Million, 2020-2031
Figure 38: U.S. Orthopedic Imaging Modalities Market (by Modality)
Figure 39: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by Modality), 2021-2031
Figure 40: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by Modality), 2021-2031
Figure 41: U.S. Orthopedic Imaging Modalities Market (X-Ray), Market Dynamics
Figure 42: Key Trends in X-Ray
Figure 43: U.S. Orthopedic Imaging Modalities Market (X-Ray), Procedure Volume, 2020-2031
Figure 44: U.S. Orthopedic Imaging Modalities Market, X-Ray (by Application), Procedure Volume, 2020-2031
Figure 45: U.S. Orthopedic Imaging Modalities Market X-Ray (by State), Procedure Volume, 2021
Figure 46: U.S. Orthopedic Imaging Modalities Market (X-Ray), $Million, 2020-2031
Figure 47: U.S. Orthopedic Imaging Modalities Market, X-Ray (by Application), $Million, 2020-2031
Figure 48: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanners, Market Dynamics
Figure 49: Key Trends in Computed Tomography (CT) Scanners
Figure 50: U.S. Orthopedic Imaging Modalities Market (Computed Tomography (CT) Scanners), Procedure Volume, 2020-2031
Figure 51: U.S. Orthopedic Imaging Modalities Market, Computed Tomography Scanners (by Application), Procedure Volume, 2020-2031
Figure 52: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanner (by State), Procedure Volume, 2021
Figure 53: U.S. Orthopedic Imaging Modalities Market (Computed Tomography (CT) Scanners), $Million, 2020-2031
Figure 54: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanners (by Application), $Million, 2020-2031
Figure 55: Types of Magnetic Resonance Imaging (MRI) Systems
Figure 56: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), Market Dynamics
Figure 57: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI ) Systems), Market Trends
Figure 58: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), Procedure Volume, 2020-2031
Figure 59: U.S. Orthopedic Imaging Modalities Market, MRI Systems (by Application), Procedure Volume, 2020-2031
Figure 60: U.S. Orthopedic Imaging Modalities Market, Magnetic Resonance Imaging (MRI) Systems (by State), Procedure Volume, 2021
Figure 61: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), $Million, 2020-2031
Figure 62: U.S. Orthopedic Imaging Modalities Market, Magnetic Resonance Imaging (MRI) Systems (by Application), $Million, 2020-2031
Figure 63: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), Market Dynamics
Figure 64: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), Procedure Volume, 2020-2031
Figure 65: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by Application), Procedure Volume, 2020-2031
Figure 66: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by State), Procedure Volume, 2021
Figure 67: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), $Million, 2020-2031
Figure 68: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by Application), $Million, 2020-2031
Figure 69: U.S. Orthopedic Imaging Modalities Market (by End User)
Figure 70: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by End User), 2021-2031
Figure 71: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by End User), 2021-2031
Figure 72: U.S. Orthopedic Imaging Modalities Market (Hospitals), $Million, 2020-2031
Figure 73: U.S. Orthopedic Imaging Modalities Market (Ambulatory Surgery Centers), $Million, 2020-2031
Figure 74: U.S. Orthopedic Imaging Modalities Market (Others), $Million, 2020-2031
Figure 75: U.S. Orthopedic Surgical Navigation Systems Market (by Application)
Figure 76: U.S. Orthopedic Surgical Navigation Systems Market, Incremental Opportunity (by Application), 2021-2031
Figure 77: U.S. Orthopedic Surgical Navigation Systems Market, Growth-Share Matrix (by Application), 2021-2031
Figure 78: U.S. Orthopedic Surgical Navigation Systems Market (Joints), $Million, 2020-2031
Figure 79: U.S. Orthopedic Surgical Navigation Systems Market (Joints), $Million, 2020-2031
Figure 80: U.S. Orthopedic Surgical Navigation Systems Market (Spine), $Million, 2020-2022
Figure 81: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Total Number of Key Developments, January 2012-September 2022
Figure 82: Regulatory and Legal Activities, January 2019- September 2022
Figure 83: New Offerings, January 2019-September 2022
Figure 84: Mergers and Acquisitions, January 2019-September 2022
Figure 85: Partnerships, Alliances, and Business Expansion Activities, January 2019-September 2022
Figure 86: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Key Development Analysis, January 2012-September 2022
Figure 87: Canon Inc.: Some of the Product Portfolio
Figure 88: Canon, Inc.: Overall Financials, $Million, 2019-2021
Figure 89: Canon, Inc.: Net Revenue (by Segment), $Million, 2019-2021
Figure 90: Canon, Inc.: Revenue (by Region), 2019-2021
Figure 91: Canon, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 92: FUJIFILM Holdings Corporation: Some of the Product Portfolio
Figure 93: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2019-2021
Figure 94: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2021
Figure 95: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2018-2020
Figure 96: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2018-2020
Figure 97: General Electric Company: Some of the Product Portfolio
Figure 98: General Electric Company.: Overall Financials, $Million, 2019-2021
Figure 99: General Electric Company: Net Revenue (by Segment), $Million, 2019-2021
Figure 100: General Electric Company: Net Revenue (by Region), $Million, 2019-2021
Figure 101: General Electric Company: R&D Expenditure, $Million, 2019-2021
Figure 102: Johnson & Johnson: Overall Product Portfolio
Figure 103: Johnson & Johnson: Overall Financials, $Million, 2019-2021
Figure 104: Johnson & Johnson: Revenue (by Segment), $Million, 2019-2021
Figure 105: Johnson & Johnson: Revenue (by Region), $Million 2019-2021
Figure 106: Johnson & Johnson: R&D Expenditure, $Million, 2019-2021
Figure 107: Konica Minolta, Inc.: Overall Product Portfolio
Figure 108: Konica Minolta, Inc.: Overall Financials 2019-2021
Figure 109: Konica Minolta, Inc.: Net Revenue (by Segment), $Million, 2019-2021
Figure 110: Konica Minolta, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 111: Konica Minolta, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 112: Koninklijke Philips N.V.: Some of the Product Portfolio
Figure 113: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021
Figure 114: Koninklijke Philips N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 115: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2019-2021
Figure 116: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021
Figure 117: Medtronic plc: Overall Product Portfolio
Figure 118: Medtronic plc: Overall Financials, $Million, 2020-2022
Figure 119: Medtronic plc: Revenue (by Segment), $Million, 2020-2022
Figure 120: Medtronic plc: Revenue (by Region), $Million 2020-2022
Figure 121: Medtronic plc: R&D Expenditure, $Million, 2020-2022
Figure 122: OrthAlign, Inc.: Some of the Product Portfolio
Figure 123: Shimadzu Corporation: Some of the Product Portfolio
Figure 124: Shimadzu Corporation: Overall Financials, $Million, 2019-2021
Figure 125: Shimadzu Corporation: Net Revenue (by Segment), $Million, 2019-2021
Figure 126: Shimadzu Corporation: R&D Expenditure, $Million, 2019-2021
Figure 127: Siemens Healthineers AG: Some of the Product Portfolio
Figure 128: Siemens Healthineers AG: Overall Financials, $Million, 2019-2021
Figure 129: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2019-2021
Figure 130: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2019-2021
Figure 131: Siemens Healthineers AG: R&D Expenditure, $Million, 2019-2021
Figure 132: Smith & Nephew plc: Overall Product Portfolio
Figure 133: Smith & Nephew plc: Overall Financials, $Million, 2019-2021
Figure 134: Smith & Nephew plc: Revenue (by Segment), $Million, 2019-2021
Figure 135: Smith & Nephew plc: Revenue (by Region), $Million 2019-2021
Figure 136: Smith & Nephew plc: R&D Expenditure, $Million, 2019-2021
Figure 137: SonoScape Medical Corp.: Overall Product Portfolio
Figure 138: Stryker Corporation: Overall Product Portfolio
Figure 139: Stryker Corporation: Overall Financials, $Million, 2019-2021
Figure 140: Stryker Corporation: Revenue (by Segment), $Million, 2019-2021
Figure 141: Stryker Corporation: Sub-Segment Revenues (MedSurg and Neurotechnology), $Million 2019-2021
Figure 142: Stryker Corporation: Revenue (by Region), $Million 2019-2021
Figure 143: Stryker Corporation: R&D Expenditure, $Million, 2019-2021
Figure 144: United Imaging Healthcare Co., Ltd.: Overall Product Portfolio
Figure 145: Zimmer Biomet Holdings, Inc.: Product Portfolio
Figure 146: Zimmer Biomet Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 147: Zimmer Biomet Holdings, Inc.: Revenue (by Segment), $Million, 2020-2021
Figure 148: Zimmer Biomet Holdings, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 149: Zimmer Biomet Holdings, Inc.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Key Questions Answered in this Report
Table 2: Parameters for Realistic, Optimistic, and Realistic Growth Scenarios
Table 3: Parameters for Realistic, Optimistic, and Realistic Growth Scenarios
Table 4: U.S. Orthopedic Imaging Modalities Market, Awaited Technologies
Table 5: U.S. Orthopedic Surgical Navigation Systems Market, Awaited Technologies
Table 6: Types of X-Rays (by Modality)
Table 7: Types of Ultrasound Systems (by Technology)
Table 8: Canon Inc.: Key Products and Features
Table 9: FUJIFILM Holdings Corporation: Key Products and Features
Table 10: General Electric Company: Key Products and Features
Table 11: Johnson & Johnson: Key Products and Features
Table 12: Konica Minolta, Inc.: Key Products and Features
Table 13: Koninklijke Philips N.V.: Key Products and Features
Table 14: Medtronic plc: Key Products and Features
Table 15: OrthAlign, Inc.: Key Products and Features
Table 16: Shimadzu Corporation: Key Products and Features
Table 17: Siemens Healthineers AG: Key Products and Features
Table 18: Smith & Nephew plc: Key Products and Features
Table 19: SonoScape Medical Corp.: Key Products and Features
Table 20: Stryker Corporation: Key Products and Features
Table 21: United Imaging Healthcare Co., Ltd.: Key Products and Features
Table 22: Zimmer Biomet Holdings, Inc.: Key Products and Features
Reviews
There are no reviews yet.